DJIA 17,602.04 161.45 0.93%
NASDAQ 5,081.05 41.28 0.82%
S&P 500 2,090.82 23.18 1.12%
market minute promo

9.49 0.36 (3.94%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $9.49 3.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.87
Previous Close $9.13
Daily Range $9.07 - $11.15
52-Week Range $4.26 - $11.15
Market Cap $660.9M
P/E Ratio 152.17
Dividend (Yield) $0.00 (0.0%)
Volume 3,745,150
Average Daily Volume 1,788,056
Current FY EPS -$0.50

Sector

Healthcare

Industry

Drug Makers

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

Why Progenics Pharmaceuticals' Stock Bolted Higher Today

Shares of Progenics Pharmaceuticals briefly popped today. Here's why.

Mid-Morning Market Update: Markets Rise; Ford Beats Q2 Estimates

Mid-Morning Market Update: Markets Rise; Ford Beats Q2 Estimates

Stocks Hitting 52-Week Highs

Stock To Watch: Progenics Pharmaceuticals (PGNX) In Perilous Reversal

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Moving Average Crossover Alert: Progenics Pharmaceuticals (PGNX) - Tale of the Tape

Moving Average Crossover Alert: Progenics Pharmaceuticals (PGNX) - Tale of the Tape

Is Progenics Pharmaceuticals (PGNX) Stock a Solid Choice Right Now? - Tale of the Tape

Allergan (AGN) Eyes Dry Eye Disease Company, Oculeve - Analyst Blog

Allergan (AGN) Eyes Dry Eye Disease Company, Oculeve - Analyst Blog

Azedra Represents A Major Opportunity For Progenix

See More PGNX News...

PGNX's Top Competitors

PGNX $9.49 (3.94%)
Current stock: PGNX
AMGN $173.16 (4.60%)
Current stock: AMGN
GILD $112.89 (2.13%)
Current stock: GILD
BIIB $317.30 (2.54%)
Current stock: BIIB